Publication | Closed Access

Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer

Breast OncologyMedicineCancer GenomicsActive Kinase ProfilingBreast CancerTriple-negative Breast CancerCell BiologyTumor SuppressorSystems BiologyOncologyRadiation OncologyImportant Common TargetTumor Biology